Celerion

Celerion expands lab capabilities for cell-based assay demand

Monday, November 3, 2014 02:36 PM

Celerion, a Lincoln, Neb.-based provider of early clinical research, has expanded laboratory capabilities to meet growing demand for cell-based assays. Assays involving whole cells provide a variety of measures of drug activity or effect that can be important endpoints in clinical research.

More... »

Quest Diagnostics

Celerion joins Cardiac Safety Research Consortium

Thursday, October 16, 2014 07:00 AM

Celerion, a Lincoln, Neb.-based provider of cardiovascular safety services in early clinical research, has become a member of the Cardiac Safety Research Consortium (CSRC). Celerion will engage with other thought leaders on key issues that impact cardiovascular safety, including discussions of alternative approaches to ICH E14 to assess arrhythmia liability in early drug development.

More... »


Celerion expands to Singapore, names Chew Lan Chong executive director

Wednesday, June 4, 2014 01:25 PM

Celerion has expanded its formal business presence in Singapore, and has named Dr. Chew Lan Chong, MBBS, MRCS, MSc, executive director, medical research, of its new operations. Chong has 10 years of direct operational experience leading clinical pharmacology units.

More... »

Celerion, Korean Drug Development Fund collaborate on early phase clinical research

Wednesday, May 28, 2014 12:52 PM

Celerion and the Korean Drug Development Fund (KDDF) are collaborating to provide drug development experience and support for South Korea’s emerging drug discovery and development industry. 

More... »

Celerion opens at Seoul National University Hospital Clinical Trial Center

Wednesday, March 5, 2014 01:05 PM

Celerion, a provider of early clinical research, has expanded clinical operations to South Korea. Through a partnership with Seoul National University Hospital (SNUH), the new Asian office is located within the SNUH Clinical Trials Center, giving Celerion and its clients access to the 80-bed clinical research unit, particularly geared toward clinical pharmacology, oncology and pediatrics.

More... »

Parthenon Capital acquires Bracket

Friday, August 16, 2013 10:15 AM

Bracket, a specialty services provider, has been acquired by Parthenon Capital Partners, a growth-oriented private equity firm based in Boston and San Francisco, from Express Scripts Holding Company.

More... »

Celerion becomes first U.S.-based CRO to receive full AAHRPP accreditation

Monday, September 17, 2012 03:39 PM

Celerion, a provider of innovative early stage drug development solutions based in Lincoln, Neb., has been awarded full accreditation by the Association for the Accreditation Human Research Protection Programs (AAHRPP), an independent, non-profit accrediting body. Celerion's clinical facilities in Lincoln, Neptune, N.J. and Phoenix, Ariz., have achieved the milestone.

More... »

Akesis names John L. Capicchioni as new president

Thursday, May 31, 2012 12:34 PM

Akesis, a Lake Wylie, S.C.-based contract research firm specializing in phase II-IV clinical dermatology services and regulatory affairs consulting, has appointed John L. Capicchioni as its new president.

More... »

Celerion and Ricerca Biosciences form The Biosimilars Alliance

Thursday, March 1, 2012 11:23 AM

Lincoln, Neb.-based Celerion, a provider of early-stage drug development solutions, and Ricerca Biosciences, which offer discovery, preclinical and development services, have formed “The Biosimilars Alliance,” focused on preclinical and early clinical assessment of biologics manufactured by a new supplier.

More... »

Celerion receives ANVISA certification

Friday, June 10, 2011 11:33 AM

Lincoln, Neb.-based Celerion, a provider of early-stage drug development solutions, has announced that its clinical research operations in Belfast, Northern Ireland, and its clinical research and bioanalytical services operations in Lincoln, Neb., have been certified by the Brazilian National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária – ANVISA). 

More... »


CWWeekly

April 27

Doctors, patients in the U.S. and U.K. agree: Mobile health apps are good for our health

AARP teams with Georgia Tech's HomeLab, Pfizer and UnitedHealthcare to test wearables with consumers 50+

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs